151 related articles for article (PubMed ID: 26452325)
1. Special issue on vaginal drug delivery.
de Oliveira RP; de Oliveira JM; Caramella C
Adv Drug Deliv Rev; 2015 Sep; 92():1. PubMed ID: 26452325
[No Abstract] [Full Text] [Related]
2. Mucoadhesive and thermogelling systems for vaginal drug delivery.
Caramella CM; Rossi S; Ferrari F; Bonferoni MC; Sandri G
Adv Drug Deliv Rev; 2015 Sep; 92():39-52. PubMed ID: 25683694
[TBL] [Abstract][Full Text] [Related]
3. New strategies for local treatment of vaginal infections.
Palmeira-de-Oliveira R; Palmeira-de-Oliveira A; Martinez-de-Oliveira J
Adv Drug Deliv Rev; 2015 Sep; 92():105-22. PubMed ID: 26144995
[TBL] [Abstract][Full Text] [Related]
4. Recent advances on anti-HIV vaginal delivery systems development.
Antimisiaris SG; Mourtas S
Adv Drug Deliv Rev; 2015 Sep; 92():123-45. PubMed ID: 25858666
[TBL] [Abstract][Full Text] [Related]
5. Acceptability and preferences for vaginal dosage forms intended for prevention of HIV or HIV and pregnancy.
Woodsong C; Holt JD
Adv Drug Deliv Rev; 2015 Sep; 92():146-54. PubMed ID: 25703190
[TBL] [Abstract][Full Text] [Related]
6. Polymer-based nanocarriers for vaginal drug delivery.
das Neves J; Nunes R; Machado A; Sarmento B
Adv Drug Deliv Rev; 2015 Sep; 92():53-70. PubMed ID: 25550217
[TBL] [Abstract][Full Text] [Related]
7. Vaginal drug distribution modeling.
Katz DF; Yuan A; Gao Y
Adv Drug Deliv Rev; 2015 Sep; 92():2-13. PubMed ID: 25933938
[TBL] [Abstract][Full Text] [Related]
8. The vagina as a route for systemic drug delivery.
Hussain A; Ahsan F
J Control Release; 2005 Mar; 103(2):301-13. PubMed ID: 15763615
[TBL] [Abstract][Full Text] [Related]
9. Since menopause I've been bothered by vaginal dryness. Is there something that can relieve the irritation and prevent discomfort during intercourse?
Mayo Clin Health Lett; 1998 Feb; 16(2):8. PubMed ID: 9516366
[No Abstract] [Full Text] [Related]
10. Distribution of a 3.5-mL (1.0%) C31G vaginal gel using magnetic resonance imaging.
Barnhart KT; Pretorius ES; Timbers K; Shera D; Shabbout M; Malamud D
Contraception; 2005 May; 71(5):357-61. PubMed ID: 15854637
[TBL] [Abstract][Full Text] [Related]
11. Vaginal films for drug delivery.
Machado RM; Palmeira-de-Oliveira A; Martinez-De-Oliveira J; Palmeira-de-Oliveira R
J Pharm Sci; 2013 Jul; 102(7):2069-81. PubMed ID: 23649325
[TBL] [Abstract][Full Text] [Related]
12. Development and characterization of a solid dispersion film for the vaginal application of the anti-HIV microbicide UAMC01398.
Grammen C; Van den Mooter G; Appeltans B; Michiels J; Crucitti T; Ariën KK; Augustyns K; Augustijns P; Brouwers J
Int J Pharm; 2014 Nov; 475(1-2):238-44. PubMed ID: 25175729
[TBL] [Abstract][Full Text] [Related]
13. Distribution of a vaginal gel (Invisible Condom) before, during and after simulated sexual intercourse and its persistence when delivered by two different vaginal applicators: a magnetic resonance imaging study.
Omar RF; Trottier S; Brousseau G; Lamarre A; Alexandre Gagnon ; Bergeron MG
Contraception; 2008 Jun; 77(6):447-55. PubMed ID: 18477496
[TBL] [Abstract][Full Text] [Related]
14. Universal vaginal applicator for the uniform distribution of vaginal gel and cream formulations: a magnetic resonance imaging study.
Omar RF; Trottier S; Brousseau G; Ouellet C; Danylo A; Ong T; Bergeron MG
J Obstet Gynaecol Can; 2014 Jan; 36(1):42-50. PubMed ID: 24444286
[TBL] [Abstract][Full Text] [Related]
15. Development and verification of mechanistic vaginal absorption and metabolism model to predict systemic exposure after vaginal ring and gel application.
Thakur K; Telaprolu KC; Paterson D; Salem F; Arora S; Polak S
Br J Clin Pharmacol; 2024 Jun; 90(6):1428-1449. PubMed ID: 38450818
[TBL] [Abstract][Full Text] [Related]
16. Optical imaging and analysis of human vaginal coating by drug delivery gels.
Henderson MH; Couchman GM; Walmer DK; Peters JJ; Owen DH; Brown MA; Lavine ML; Katz DF
Contraception; 2007 Feb; 75(2):142-51. PubMed ID: 17241845
[TBL] [Abstract][Full Text] [Related]
17. [Lubrication reduces difficulties during sexual intercourse after gynecological surgery].
Picha E
Akush Ginekol (Sofiia); 2002; 41 Suppl 1():33-5. PubMed ID: 12412353
[No Abstract] [Full Text] [Related]
18. A multicentre Australian trial of low dose estradiol therapy for symptoms of vaginal atrophy using a vaginal ring as delivery system.
Fraser IS; Ayton R; Farrell E; Weisberg E; Darling G; Murkies A
Maturitas; 1995 Dec; 22 Suppl():S41. PubMed ID: 8775776
[No Abstract] [Full Text] [Related]
19. Formulation studies of benzydamine mucoadhesive formulations for vaginal administration.
Perioli L; Ambrogi V; Venezia L; Giovagnoli S; Pagano C; Rossi C
Drug Dev Ind Pharm; 2009 Jul; 35(7):769-79. PubMed ID: 19337872
[TBL] [Abstract][Full Text] [Related]
20. Spreading and retention of vaginal formulations in post-menopausal women as assessed by gamma scintigraphy.
Brown J; Hooper G; Kenyon CJ; Haines S; Burt J; Humphries JM; Newman SP; Davis SS; Sparrow RA; Wilding IR
Pharm Res; 1997 Aug; 14(8):1073-8. PubMed ID: 9279891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
